NEW YORK, May 9, 2016 /PRNewswire/ --
Amaya, Inc. (AYA)
Lifshitz & Miller announces investigation on behalf of Amaya investors. Specifically, on March 23, 2016, news outlets reported that Amaya's CEO, was charged with insider trading by Quebec securities regulators.
Chiasma, Inc. (CHMA)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by SGI board. Specifically, on April 15, 2016, Chiasma announced that the FDA rejected Chiasma's NDA for Mycapssa(octreotide)capsules.
Intrexon Corporation (XON)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the Intrexon board. Specifically, on April 21, 2016, Spotlight Research issued a report revealing Intrexon's revenues were overstated through related party transactions.
Natus Medical Inc. (BABY)
Lifshitz & Miller announces investigation on behalf of Natus investors in connection with its expected receipt of prepayments under a contract with the Venezuelan Government and the timing of certain insiders' stock sales, potentially in violation of the securities laws.
NRG Yield, Inc. (NYLD)
Lifshitz & Miller announces investigation on behalf of NRG investors. Specifically, whether NRG adequately disclosed in its June 29, 2015 Class C Common Stock Offering (the "Offering"), material facts and trends that may have a significant adverse impact on NRG's performance and results for the second quarter of 2015.
Sunrun Inc. (RUN)
Lifshitz & Miller announces investigation on behalf of Sunrun investors. Specifically, whether Sunrun adequately disclosed in its August 5, 2015 IPO, its reliance on complex debt arrangements to fund its growth and ability to sustain its revenues.
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the TransEnterix board. Specifically, on April 20, 2016, TransEnterix announced that the FDA determined that the "SurgiBot™ System does not meet the criteria for substantial equivalence.
Vivint Solar, Inc. (VSLR)
Lifshitz & Miller announces investigation on behalf of VSLR investors in connection with the failed acquisition of Vivint by SunEdison Inc. due to the lack of financing and liquidity.
ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-amaya-inc-chiasma-inc-intrexon-corporation-natus-medical-inc-nrg-yield-inc-sunrun-inc-transenterix-and-vivint-solar-inc-300265429.html
SOURCE Lifshitz & Miller Law Firm